Demographic, clinical characteristics and degree of glycaemic control of patients with T2DM by year
| 2007 N=257 072 | 2008 N=271 690 | 2009 N=286 019 | 2010 N=301 144 | 2011 N=317 215 | 2012 N=331 317 | 2013 N=343 969 | Change 2007–2013 (95% CI) | |
|---|---|---|---|---|---|---|---|---|
| Age, mean (SD), years | 67.7 (11.7) | 67.9 (11.8) | 68.1 (11.8) | 68.2 (11.9) | 68.4 (12.0) | 68.6 (12.1) | 68.9 (12.1) | 1.20 (1.14 to 1.26) |
| Males, % | 52.2 | 52.7 | 53.2 | 53.6 | 53.9 | 54.1 | 54.3 | 2.15 (1.90 to 2.40) |
| T2DM duration, mean (SD), years | 5.4 (5.3) | 5.9 (5.3) | 6.3 (5.3) | 6.7 (5.4) | 7.0 (5.5) | 7.4 (5.6) | 7.8 (5.6) | 2.40 (2.37 to 2.43) |
| BMI, mean (SD), kg/m2 | 30.1 (5.0) | 30.1 (5.0) | 30.1 (5.0) | 30.1 (5.0) | 30.1 (5.1) | 30.0 (5.1) | 30.0 (5.1) | −0.08 (−0.11 to −0.05) |
| Obesity (BMI>30 kg/m2), % | 45.6 | 45.5 | 45.3 | 45.7 | 45.3 | 45.1 | 45.1 | −0.043 (−0.12 to −0.74) |
| HbA1c*, mean (SD), % | 7.16 (1.46) | 7.23 (1.48) | 7.25 (1.47) | 7.19 (1.40) | 7.20 (1.36) | 7.30 (1.35) | 7.24 (1.35) | 0.08 (0.07 to 0.09) |
| HbA1c≤7%, % | 54.9 | 52.8 | 52.2 | 55.1 | 55.6 | 52.6 | 55.2 | 0.29 (−0.02 to 0.60)† |
| HbA1c≤8%*, % | 78.9 | 77.8 | 77.9 | 79.3 | 79.6 | 78.4 | 79.6 | 0.64 (0.39 to 0.89) |
| Individualised HbA1c target‡, % | 75.4 | 73.2 | 72.8 | 74.8 | 75.4 | 73.7 | 75.7 | 1.15 (0.88 to 1.42) |
*Cut-off stated by the ICS.
†The CI contains the null change (0), and therefore it is not statistically significant.
‡On the basis of the 2014 algorithm of the Red-GDPS.
BMI, body mass index; HbA1c, glycated haemoglobin; ICS, Institut Català de la Salut; Red-GDPS, Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud; T2DM, type 2 diabetes mellitus.